GTG 2.22% 9.2¢ genetic technologies limited

I do think BrevaGEN will be enough and that is why they are...

  1. 1,181 Posts.
    lightbulb Created with Sketch. 12
    I do think BrevaGEN will be enough and that is why they are putting all their eggs into this basket (selling down their holding in ImmunAID and not focusing so much on .

    However if you compare Pacific Edge, they have gone into the US after us and have a much higher MC.

    Why is that?

    IMO, I think it is MJ. Nothing against him but if I compare AHZ, AVX had a large holding in AHZ. When they sold out completely, look at where AHZ SP is now. I think large holders can hold the SP back especially if they can be destabilising (MJ pretty much rolled the previous board). But I don't know whether he will sell out unless the SP is much higher than where it is now.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
9.2¢
Change
0.002(2.22%)
Mkt cap ! $12.16M
Open High Low Value Volume
8.7¢ 9.2¢ 8.7¢ $2.809K 31.31K

Buyers (Bids)

No. Vol. Price($)
1 50000 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.2¢ 484 1
View Market Depth
Last trade - 15.53pm 21/06/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.